Detalles de la búsqueda
1.
Living well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors.
Contemp Clin Trials;
: 107612, 2024 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38914309
2.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
J Clin Oncol;
42(3): 283-299, 2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864337
3.
Diagnostic challenges in differentiating between hydropic abortus, and complete and partial hydatidiform molar pregnancies in early gestation.
Int J Gynecol Cancer;
33(9): 1482-1484, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268312
4.
Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2.
JCO Precis Oncol;
7: e2200421, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37053535
5.
Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer.
Cancer Res Commun;
2(10): 1282-1292, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36311816
6.
The feasibility of screening for malnutrition in the outpatient setting and the prevalence of malnutrition in patients with newly-diagnosed ovarian carcinoma.
Gynecol Oncol Rep;
43: 101052, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35958956
7.
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas.
Gynecol Oncol;
163(1): 130-133, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452747
8.
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.
Gynecol Oncol;
160(3): 786-792, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33375991
9.
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Gynecol Oncol;
159(1): 214-220, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709535
10.
Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Gynecol Oncol;
157(2): 514-520, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32199636
11.
Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention.
Fam Cancer;
19(2): 143-151, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096072
12.
An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions.
Int J Gynecol Pathol;
39(3): 261-269, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31033800
13.
Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
Gynecol Oncol;
156(3): 517-522, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883735
14.
Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations.
Gynecol Oncol Rep;
29: 113-117, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467964
15.
Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma.
Gynecol Oncol;
153(2): 217-222, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30803719
16.
Revisiting Minimally Invasive Surgery in the Management of Early-Stage Cervical Cancer.
J Natl Compr Canc Netw;
17(1): 86-90, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30659132
17.
Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
Gynecol Oncol;
153(1): 192-200, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30661763
18.
Evaluation of Intraoperative Assessments in the Management of Endometrial Carcinoma: A Retrospective Quality Assurance Review.
Int J Gynecol Pathol;
37(5): 414-420, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30102260
19.
The role of physical activity in breast and gynecologic cancer survivorship.
Gynecol Oncol;
149(1): 198-204, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395306
20.
Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma.
Gynecol Oncol;
148(2): 281-285, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233532